Printer Friendly
The Free Library
6,672,335 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Veridien Adds Hepatitis A, B and C Kill Claims to Its FDA Drug Listed Products.


Business Editors/Health/Medical Writers

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Dec. 23, 2003

Highlights

-- Independent testing confirms new Hepatitis A, B, and C kill

claims

-- Veridien's FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 drug listed products to carry Hepatitis A, B

and C kill claims starting January 2004

-- Hepatitis A, B, and C kill claims provide new revenue

opportunities for 2004 and beyond

Veridien Corporation (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:VRDE) announced today that its patented formula used in its FDA drug listed Viraguard(R) Antiseptic Hand Sprays, Hand Gels and Hand Wipes, has been proven to kill Hepatitis A, B and C viruses. Sheldon Fenton, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said: "The Company has positioned its patented products to substantially increase revenue opportunities in tandem with national and multi-national distributors. The Hepatitis kill claims should increase demand for Veridien's Infection Control Products in multiple markets."

Veridien's Antiseptic Products are effective tools for healthcare professionals to minimize the spread of diseases caused by many viruses and bacteria. Alcohol based hand rubs are recommended by the Centers For Disease Control in their Hand Hygiene Guidelines. The active ingredient in Veridien's patented formulation is isopropyl alcohol. In vitro testing has proven Veridien's patented formula to kill Hepatitis A, B, and C, HIV-1(Aids virus), Methicillin-resistant Staphylococcus aureus methicillin-resistant Staphylococcus aureus Methicillin-aminoglycoside resistant Staphylococcus aureus, MRSA An organism with multiple antibiotic resistances–eg, aminoglycosides, chloramphenicol, clindamycin, erythromycin, rifampin, tetracycline,  (MRSA MRSA Methicillin-resistant Staphylococcus aureus. See MARSA. ), Vancomycin-resistant Enterococcus faecalis (VRE VRE

vancomycin-resistant enterococcus.

VRE Vancomycin-resistent enterococcus, see there
), Herpes Simplex-type2, Escheria coli (E.coli) strain 157, Mycobacterium bovis (BCG BCG bacille Calmette-Guérin.

BCG
abbr.
1. bacillus Calmette-Guérin

2. ballistocardiogram


BCG,
n.pr See bacille Calmette-Guórin.
,TB surrogate), Pseudomonas aeruginosa, Streptococcus Pyogenes (Strep), Salmonella choleraesius, Staphylococcus aureus, Respiratory syncytial virus respiratory syncytial virus (sĭnsĭsh`əl): see cold, common.  (RSV RSV respiratory syncytial virus; Rous sarcoma virus.

RSV
abbr.
respiratory syncytial virus


RSV 1 Respiratory syncytial virus, see there 2 Rous sarcoma virus, see there
), Rotavirus (SA-11 Group A), Influenza type1 - 2, Trichophyton mentagrophytes(athlete's foot fungus), Cytomegalovirus (CMV) and Adenovirus-Type 2.

Paul Dunnigan, VP-Marketing Group, said: "Based on conversations with our customer base, we expect the enhanced kill claims to positively impact our revenues for 2004 and beyond. With the recent virulent outbreaks of Hepatitis and Influenza across North America, Veridien's Patented Infection Control Products should provide healthcare professionals and consumers alike with effective tools to help prevent the spread of illness in the workplace and at home."

Veridien's Infection Control Products are available to healthcare professionals through major medical distributors, and to consumers at http://www.buyveridien.com. Effective January 2004, Viraguard(R) Antiseptic Infection Control Products will carry the Hepatitis A, B and C kill claims.

About Veridien

Veridien Corporation is a Health Care Company focusing on Infection Control and other Healthy Lifestyle products. Veridien has developed PATENTED and UNIQUE PRODUCTS including SURFACE DISINFECTANTS, ANTISEPTIC HAND CLEANSERS, INSTRUMENT PRESOAK, AND SUN PROTECTANT PRODUCTS. The flagship product Viraguard(R) Hospital Disinfectant/Cleaner and Instrument Presoak is a skin friendly, patented, U.S. - EPA EPA eicosapentaenoic acid.

EPA
abbr.
eicosapentaenoic acid


EPA,
n.pr See acid, eicosapentaenoic.

EPA,
n.
 and Health Canada registered, surface disinfectant. Viraguard(R) Hospital Surface Disinfectant Towelettes and Viraguard (R) Toilet Seat Wipes (Sit Secure (TM) program) are also U.S.- EPA registered. Viraguard(R) Antiseptic Hand Gel, Viraguard(R) Antiseptic Hand Spray and Viraguard(R) Antiseptic Hand Wipes are all U.S. - FDA and Health Canada drug listed products utilizing Veridien's patented Virahol(R) formulation.

Look for Veridien at http://www.veridien.com

Special Note: Forward-looking statements in this press release are made pursuant to the "safe-harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Investors are cautioned that such forward-looking statement involve risks and uncertainties, including without limitation, market acceptance of, and demand for, the Company's products, manufacturing, development and distributor issues, product pricing, competition, funding availability, technological changes and other risks not identified herein. The Company disclaims any intent or obligation to update any forward-looking statements.

"HEALTHY LIVING IS AN ADVENTURE - LET VERIDIEN GUIDE YOU"
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Dec 23, 2003
Words:567
Previous Article:The FCC Grants SkyWay Communications Holding Corp Authorization to Utilize Existing Air to Ground Frequency License.
Next Article:MeriStar Hospitality Closes on New $50 Million Credit Facility; Company Also Exchanges Common Stock for 8-3/4% Senior Subordinated Notes.
Topics:



Related Articles
Warning: cutting the FDA could be hazardous to your health. (Food and Drug Administration)(Inside the Executive Branch)
Tenofovir: FDA Hearing on Important New Antiretroviral.(Viread from Gilead Sciences)
A WHOLE NEW BALLGAME; AFTER HOME RUNS WITH ITS FIRST TWO DRUGS, AMGEN TRIES TO PUT ITS HEPATITIS C PRODUCT IN PLAY.(BUSINESS)(Statistical Data...
FDA ISSUES WARNING NOT TO USE TESTS.(BUSINESS)
New prescription food labels.(Brief Article)
Blood supply scrutinized: FDA report cites more than 200 violations.
Regulation for dummies: is the FDA necessary?(Culture and Reviews)(book)(Book Review)
FDA AIDS announcements, first quarter 2005.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles